Pediatrics HOT COVID-19 Database in NY Tristate
Purpose
New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are, the investigators are uniquely positioned to inform the rest of the country about what to expect and how to manage children and young adults with hematological, oncological or stem cell transplant diagnoses during the pandemic.
Conditions
- Pediatric Cancer
- Immune System Disorder
- COVID-19
- Hemoglobinopathies
Eligibility
- Eligible Ages
- Under 21 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Hematologic, Oncologic or Stem Cell Transplant Diagnosis - Tested for COVID-19 - Age up to 21 years of age
Exclusion Criteria
- Unwillingness to participate
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Other
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Heme/Non-Sickle Cell Disease | Subjects with a diagnosis of hemoglobinapathy except Sickle Cell Disease | |
| Heme/Sickle Cell Disease | Subjects with a diagnosis of Sickle Cell Disease | |
| Neuro-Oncological Disease | Oncology diagnosis with involvement of the neurological system | |
| Oncology/Non-Neuro-Oncological | Subjects with any oncology diagnosis except those that involve the neurological system. | |
| Transplant patients | Subjects who have received or are intending to have a stem cell transplant for treatment of disease. |
Recruiting Locations
More Details
- NCT ID
- NCT04445402
- Status
- Completed
- Sponsor
- Columbia University
Detailed Description
The subjects are all pediatric hematology, oncology or stem cell transplant (HOT) children and young adults who are tested for SARS-CoV-2. The investigators will collect data including demographics, clinical characteristics, clinical courses, outcomes from the medical record. Other information about finances, mental health, and nutrition will be ascertained by questionnaires. The subjects will be asked to allow the researchers to abstract information from their medical record, participate in an interview or telephone call (their choice) to answer questionnaires, and to provide a stool sample at three time points. The creation of an integrated database of COVID-19 pediatric and young adult patients will better inform the pediatric hematology, oncology, and stem cell transplant community about this disease specifically related to patients undergoing HOT therapy and provide valuable evidence to develop standardized and clinically appropriate approaches to their care.